Exxon Mobil Corp
Change company Symbol lookup
Select an option...
XOM Exxon Mobil Corp
AMRC Ameresco Inc
ET Energy Transfer LP
AHCO Adapthealth Corp
LPSN LivePerson Inc
BGSF BGSF Inc
NEE Nextera Energy Inc
PSB-Y PS Business Parks Inc
ADBE Adobe Inc
APWL Advanced Powerline Technologies Inc
Go

Energy : Oil, Gas & Consumable Fuels | Large Cap Value
Company profile

Exxon Mobil Corporation is engaged in energy business. The Company is engaged in the exploration, production, trade, transportation and sale of crude oil and natural gas, and the manufacture, transportation and sale of crude oil, natural gas, petroleum products, petrochemicals and a range of specialty products. The Company's segments include Upstream, Downstream, Chemical, and Corporate and Financing. The Upstream segment operates to explore for and produce crude oil and natural gas. The Downstream manufactures, trades and sells petroleum products. The refining and supply operations consists of a global network of manufacturing plants, transportation systems, and distribution centers that provide a range of fuels, lubricants and other products and feedstocks to its customers around the world. The Chemical segment manufactures and sells petrochemicals. The Chemical business supplies olefins, polyolefins, aromatics, and a variety of other petrochemicals.

Premarket

Last Trade
Delayed
$61.60
0.32 (0.52%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$61.28
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
5,521

10-day average volume:
23,847,903
5,521

(SPPI) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Spectrum Pharmaceuticals, Inc. Class Action Lawsuit

9:40 am ET October 9, 2021 (Globe Newswire) Print

Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Spectrum Pharmaceuticals, Inc. ("Spectrum Pharmaceuticals" or the "Company") (NASDAQ: SPPI). The class action is on behalf of shareholders who purchased Spectrum Pharmaceuticals common stock between December 27, 2018 and August 5, 2021, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff in this class action, you must move the Court no later than November 1, 2021.

[click here to join this action]

According to the filed complaint: (i) the manufacturing facility for ROLONTIS, an investigational granulocyte-colony stimulating factor analog, maintained deficient controls and procedures; (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration would approve the ROLONTIS biologics license application ("BLA") in its current form; (iii) Spectrum Pharmaceuticals had therefore materially overstated the ROLONTIS BLA's approval prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

A lead plaintiff will act on behalf of all other class members in directing the Spectrum Pharmaceuticals class-action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the class-action lawsuit. An investor's ability to share any potential future recovery of the Spectrum Pharmaceuticals class action lawsuit is not dependent upon serving as lead plaintiff.

If you suffered a substantial loss and are interested in learning more about being a lead plaintiff, please contact Jim Baker (jimb@johnsonfistel.com) by email or phone at 619-814-4471. If emailing, please include a phone number.

Additionally, you can [click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:

Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:

Johnson Fistel, LLP

Jim Baker, 619-814-4471

jimb@johnsonfistel.com

[click here to join this action]

https://ml.globenewswire.com/media/OTdhZTk5MDItMTA0NS00NzkyLTkxZTAtYmU5ZGRjZGJhZjcwLTExOTMzNTg=/tiny/Johnson-Fistel-LLP.png

https://ml.globenewswire.com/media/OTdhZTk5MDItMTA0NS00NzkyLTkxZTAtYmU5ZGRjZGJhZjcwLTExOTMzNTg=/tiny/Johnson-Fistel-LLP.png

comtex tracking

COMTEX_394837651/2010/2021-10-09T09:40:22

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.